2026 Amy D. Klion: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	68	2582	2376	1231	1122	283	17468

Research.com Recognitions

2019 - Fellow of the American Society of Tropical Medicine and Hygiene (ASTMH)

Overview

Amy D. Klion is affiliated with the National Institutes of Health in the United States and has contributed extensively to the field of medicine, particularly focusing on eosinophilic disorders, immunology, and related areas.

Their research spans several main fields, including:

Medicine

Within medicine, their subfields of study include:

Rheumatology
Surgery
Immunology
Infectious Diseases
Physiology

The primary topics of their research involve:

Eosinophilic Disorders and Syndromes
Eosinophilic Esophagitis
Asthma and respiratory diseases
Parasitic Diseases Research and Treatment
Immune Cell Function and Interaction
IL-33, ST2, and ILC Pathways
Mast cells and histamine

Amy D. Klion has published in several frequent venues that include:

Journal of Allergy and Clinical Immunology
The Journal of Allergy and Clinical Immunology In Practice
Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
Gastroenterology
Blood

Recent significant papers by Amy D. Klion include:

"Contributions of Eosinophils to Human Health and Disease" (2020), published in Annual Review of Pathology Mechanisms of Disease
"A new dawn for eosinophils in the tumour microenvironment" (2020), published in Nature reviews. Cancer
"Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis" (2020), published in New England Journal of Medicine
"Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis" (2022), published in The Journal of Allergy and Clinical Immunology In Practice
"Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial" (2020), published in Journal of Allergy and Clinical Immunology

Among frequent collaborators, Amy D. Klion has coauthored numerous works with:

Paneez Khoury
Michelle Makiya
Marc E. Rothenberg
Gregory Constantine
Lauren Wetzler

Amy D. Klion received the award of Fellow of the American Society of Tropical Medicine and Hygiene (ASTMH) in 2019.

Best Publications

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

Michael E. Wechsler;Praveen Akuthota;David Jayne;Paneez Khoury

1015
Citations
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes.

Peter Valent;Amy D. Klion;Hans-Peter Horny;Florence Roufosse

851
Citations
Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources

Sebastian Köhler;Leigh Carmody;Nicole A. Vasilevsky;Julius O. B. Jacobsen

715
Citations
Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy.

Princess U. Ogbogu;Bruce S. Bochner;Joseph H. Butterfield;Gerald J. Gleich

705
Citations
Treatment of patients with the hypereosinophilic syndrome with mepolizumab

Marc E. Rothenberg;Amy D. Klion;Florence E. Roufosse;Jean Emmanuel Kahn

667
Citations
The role of eosinophils in host defense against helminth parasites

Amy D. Klion;Thomas B. Nutman

545
Citations
Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness.

Amy D. Klion;Amy D. Klion;Pierre Noel;Pierre Noel;Cem Akin;Cem Akin;Melissa A. Law;Melissa A. Law

521
Citations
Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report.

Amy D. Klion;Bruce S. Bochner;Gerald J. Gleich;Thomas B. Nutman

409
Citations
Refining the definition of hypereosinophilic syndrome

Hans-Uwe Simon;Marc E. Rothenberg;Bruce S. Bochner;Peter Fahey Weller

394
Citations
Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome.

Amy D Klion;Jamie A Robyn;Cem Akin;Pierre Noel

297
Citations
The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan

Jonathan J. Kotzin;Sean P. Spencer;Sean P. Spencer;Sam J. McCright;Dinesh B. Uthaya Kumar

286
Citations
A new dawn for eosinophils in the tumour microenvironment.

Sharon Grisaru-Tal;Michal Itan;Amy D Klion;Ariel Munitz

286
Citations
Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.

Unknown

277
Citations
How I treat hypereosinophilic syndromes

Amy D. Klion

264
Citations
Anti–Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis

Evan S. Dellon;Kathryn A. Peterson;Joseph A. Murray;Gary W. Falk

249
Citations
Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes

Florence E. Roufosse;Jean Emmanuel Kahn;Gerald J. Gleich;Lawrence B. Schwartz

240
Citations
Contributions of Eosinophils to Human Health and Disease

Amy D. Klion;Steven J. Ackerman;Bruce S. Bochner

239
Citations
Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome.

Fei Li Kuang;Fanny Legrand;Michelle Makiya;JeanAnne Ware

202
Citations
Eosinophils in vasculitis: characteristics and roles in pathogenesis

Paneez Khoury;Peter C. Grayson;Amy D. Klion

195
Citations
Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field

Peter Valent;Gerald J Gleich;Andreas Reiter;Florence Roufosse

192
Citations
A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa–Endemic Areas

Joseph Kamgno;Sébastien D Pion;Cédric B Chesnais;Matthew H Bakalar

192
Citations
Loiasis in Endemic and Nonendemic Populations: Immunologically Mediated Differences in Clinical Presentation

Amy D. Klion;Achilles Massougbodji;Benoit-Christophe Sadeler;Eric A. Ottesen

187
Citations
Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome.

Amy D. Klion;Melissa A. Law;Pierre Noel;Yae Jean Kim

177
Citations

Frequent Co-Authors

Thomas B. Nutman National Institute of Allergy and Infectious Diseases

Gerald J. Gleich University of Utah

Marc E. Rothenberg Cincinnati Children's Hospital Medical Center

Peter F. Weller Beth Israel Deaconess Medical Center

Bruce S. Bochner Northwestern University

Hans-Uwe Simon University of Bern

Dean D. Metcalfe National Institute of Allergy and Infectious Diseases

Michael E. Wechsler National Jewish Health

Cynthia E. Dunbar National Institutes of Health

Cem Akin University of Michigan–Ann Arbor

External Links

Personal website of Amy D. Klion

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden career options. Nursing programs, such as lpn programs with easiest admission requirements, offer accessible entry points into clinical roles that often intersect with immunological care.

Advancing to roles like nurse practitioners can deepen your expertise. Several easiest nurse practitioner degree programs provide flexible online formats and streamlined admissions, making career progression practical and attainable.

For those specializing in mental health, pursuing a psychiatric nurse practitioner path is complementary to Immunology, given the immune system's link to mental health conditions. The best pmhnp programs with strong clinical placement support are ideal choices.

Cost efficiency is also important. Consider the cheapest psychiatric nurse practitioner programs if budget constraints are a concern while pursuing specialized nursing education aligned with immunological care.